Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Directors Dealing

6 May 2016 10:03

RNS Number : 4957X
Restore PLC
06 May 2016
 

6 May 2016

Restore plc

("Restore" or the "Company")

Exercise of Options

Directors Dealing

Pursuant to Restore's Employee Share Option Scheme the Company has applied for 3,916,015 new ordinary shares of 5 pence each ("New Ordinary Shares") to be admitted to trading on AIM ("Admission"). The New Ordinary Shares are being issued in relation to the exercise today of options granted in 2010 and 2012 to certain employees and directors of the Company. It is expected that Admission will become effective and that dealings will commence in the New Ordinary Shares at 8.00 a.m. on 11 May 2016.

In conjunction with the option exercise and issue of New Ordinary Shares, Sir William Wells, Charles Skinner and Adam Councell, all directors of the Company, have received and simultaneously sold a number of their New Ordinary Shares as set out in the table below at a price of £3.05 per share.

Directors

Holdings

Number of

Ordinary Shares

held prior to

exercise of

options

Number of

New

Ordinary

Shares

received as

a result of

exercise of

options

Exercise

price of

options (£)

Number

of shares

sold

Interest in

Ordinary

Shares

Following

the issue

and sale of

New

Ordinary

Shares

Percentage of

total voting

rights

following the

issue of New

Ordinary

Shares

Sir William Wells

352,553

-

480,315

375,427

0.325

0.83

855,742

352,553

0.35%

Charles Skinner

541,415

-

1,260,826

937,794

0.325

0.83

1,641,243

1,098,792

1.10%

Adam Councell

-

 

294,148

0.83

148,525

145,623

0.15%

Following admission of the New Ordinary Shares there will be 99,870,775 ordinary shares in issue and admitted to trading on AIM.

Contact:

Restore plc

Charles Skinner, Chief Executive

07966 234 075

Adam Councell, Group Finance Director

07860 402 434

Cenkos Securities plc

020 7397 8900

Nicholas Wells

Elizabeth Bowman

FTI Consulting

020 3727 1340

Nick Hasell

Alex Le May

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUPUAUPQUBQ
Date   Source Headline
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company
17th Mar 20251:48 pmRNSDirector/PDMR Shareholding
14th Mar 20258:37 amRNSDirector/PDMR Shareholding
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.